← Back to all clusters

Cluster 565

5 diseases · 6 shared-gene connections
5 Diseases
46 Unique genes
0.169 Avg. similarity score
Erythematosquamous dermatosis Most-connected disease (3 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Disease ⇵ Connections in cluster ⇵ Significant partners ⇵ Curated genes ⇵
Erythematosquamous dermatosis 3 3 22
Sebaceous gland disease 3 3 14
Seborrheic dermatitis 3 3 37
Pityriasis rubra pilaris 2 2 1
Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies 1 1 1

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
CARD14 3 / 5 Erythematosquamous dermatosis, Pityriasis rubra pilaris, Seborrheic dermatitis
HERC2 3 / 5 Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis
IRF4 3 / 5 Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis
MC1R 3 / 5 Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis
RALY 3 / 5 Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis
SLC45A2 3 / 5 Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis
TYR 3 / 5 Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis
FAM8A1 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
FLYWCH2 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
FOXP1 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
IL23R 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
IL2RA 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
KLK6 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
KLK7 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
POLI 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
PRSS22 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
SPINK5 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
TAP2 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
TYK2 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
ZBTB7A 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
ZMIZ1 2 / 5 Erythematosquamous dermatosis, Seborrheic dermatitis
ZNF668 2 / 5 Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies, Sebaceous gland disease
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Interleukin-4 and Interleukin-13 signaling Reactome 5 / 108 12.1× 5.48e-5 1.17e-3 ✓ sig.
Melanin biosynthesis Reactome 2 / 5 104× 1.42e-4 2.51e-3 ✓ sig.
Interleukin-23 signaling Reactome 2 / 9 58.0× 5.08e-4 6.75e-3 ✓ sig.
Th17 cell differentiation KEGG 4 / 109 9.6× 7.81e-4 9.37e-3 ✓ sig.
Measles KEGG 4 / 139 7.5× 1.92e-3 1.85e-2 ✓ sig.
Inflammatory bowel disease KEGG 3 / 66 11.9× 2.03e-3 1.92e-2 ✓ sig.
Interferon alpha/beta signaling Reactome 3 / 67 11.7× 2.12e-3 1.99e-2 ✓ sig.
JAK-STAT signaling pathway KEGG 4 / 168 6.2× 3.82e-3 3.02e-2 ✓ sig.
Herpes simplex virus 1 infection KEGG 4 / 182 5.7× 5.07e-3 3.68e-2 ✓ sig.
Th1 and Th2 cell differentiation KEGG 3 / 93 8.4× 5.36e-3 3.82e-2 ✓ sig.
ER-Phagosome pathway Reactome 2 / 30 17.4× 5.83e-3 4.04e-2 ✓ sig.
Epstein-Barr virus infection KEGG 4 / 204 5.1× 7.56e-3 4.77e-2 ✓ sig.
Regulation of TP53 Expression Reactome 1 / 2 131× 7.65e-3 4.81e-2 ✓ sig.
Transcriptional activation of cell cycle inhibitor p21 Reactome 1 / 4 65.3× 1.52e-2 7.32e-2
Toll Like Receptor TLR6:TLR2 Cascade Reactome 1 / 4 65.3× 1.52e-2 7.32e-2

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
melanin biosynthetic process GO:0042438 3 / 14 87.1× 4.99e-6 3.17e-4 ✓ sig.
type II interferon-mediated signaling pathway GO:0060333 3 / 15 81.2× 6.22e-6 3.77e-4 ✓ sig.
melanin biosynthetic process from tyrosine GO:0006583 2 / 4 203× 3.55e-5 1.42e-3 ✓ sig.
interleukin-23-mediated signaling pathway GO:0038155 2 / 6 135× 8.84e-5 2.82e-3 ✓ sig.
positive regulation of interleukin-12 production GO:0032735 3 / 43 28.3× 1.61e-4 4.35e-3 ✓ sig.
positive regulation of natural killer cell proliferation GO:0032819 2 / 12 67.7× 3.85e-4 7.96e-3 ✓ sig.
apoptotic process GO:0006915 8 / 747 4.4× 4.26e-4 8.53e-3 ✓ sig.
positive regulation of T-helper 17 type immune response GO:2000318 2 / 13 62.5× 4.54e-4 8.91e-3 ✓ sig.
positive regulation of calcium ion-dependent exocytosis GO:0045956 2 / 14 58.0× 5.29e-4 9.88e-3 ✓ sig.
positive regulation of T cell proliferation GO:0042102 3 / 67 18.2× 5.99e-4 1.07e-2 ✓ sig.
negative regulation of androgen receptor signaling pathway GO:0060766 2 / 17 47.8× 7.87e-4 1.27e-2 ✓ sig.
inflammatory response GO:0006954 6 / 467 5.2× 9.47e-4 1.42e-2 ✓ sig.
positive regulation of NF-kappaB transcription factor activity GO:0051092 3 / 80 15.2× 1.00e-3 1.47e-2 ✓ sig.
macrophage activation GO:0042116 2 / 23 35.3× 1.45e-3 1.80e-2 ✓ sig.
protein autoprocessing GO:0016540 2 / 25 32.5× 1.72e-3 1.96e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Erythematosquamous dermatosis Seborrheic dermatitis 0.538 21 1.50e-57 4.38e-56 ✓ sig.
Erythematosquamous dermatosis Sebaceous gland disease 0.200 6 6.64e-15 7.99e-14 ✓ sig.
Sebaceous gland disease Seborrheic dermatitis 0.133 6 2.06e-13 2.30e-12 ✓ sig.
Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies Sebaceous gland disease 0.071 1 8.39e-4 1.34e-3 ✓ sig.
Erythematosquamous dermatosis Pityriasis rubra pilaris 0.043 1 1.42e-3 2.04e-3 ✓ sig.
Pityriasis rubra pilaris Seborrheic dermatitis 0.026 1 2.39e-3 3.12e-3 ✓ sig.